BAY 43-9006

A drug used to treat certain types of hepatocellular carcinoma (a type of liver cancer), renal cell carcinoma (a type of kidney cancer), and thyroid cancer. It is also being studied in the treatment of other types of cancer. BAY 43-9006 blocks certain proteins, which may help keep cancer cells from growing and dividing and may kill them. It may also prevent the growth of new blood vessels that tumors need to grow. BAY 43-9006 is a type of kinase inhibitor and a type of antiangiogenesis agent. Also called Nexavar and sorafenib tosylate.